All stock lists
SELLAS Life Sciences Group, Inc (SLS)
NASDAQ: SLS · Real-Time Price · USD
Healthcare · Biotechnology
$14.80-$3.15 (-17.55%)
SLS analyst forecast
Best analysts covering SLS
- Maxim Group100%success rate · +573.2% avg return · 1 call
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
SLS analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| — | Maxim Group | Buy | — | — | Reiterated | 2026-03-12 |
SLS earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2025-11-12 | -$0.06 | -$0.06 | $0 | $0 |
| 2026-03-19 | -$0.06 | -$0.05 | $0 | $0 |
| 2026-05-12 | -$0.06 | -$0.05 | $0 | $0 |
| 2026-08-11 | -$0.04 | -$0.05 | $0 | $0 |
| 2026-11-18Upcoming | -$0.05 | — | $0 | — |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.
